FDA Approves Eli Lilly’s Zepbound™ for Obesity Treatment
INDIANAPOLIS: Eli Lilly and Company's (NYSE: LLY) innovative obesity treatment, Zepbound™ (tirzepatide)…
Search
Have an existing account?
Sign In
Tag: Eli Lilly